---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-201733"
form_type: "8-K"
ticker: null
cik: "0001183765"
company_name: "Molecular Templates, Inc."
filed_at: "2023-08-02T23:59:59+00:00"
generated_at: "2026-06-12T11:47:57.592322+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Molecular Templates announces C-suite reshuffle: interim CMO, President/CFO, COO, CSO

## Summary
- Roger Waltzman resigns as CMO effective Aug 4, 2023; no disagreement cited.
- Gabriela Gruia appointed interim CMO; $471,960 base salary, option for 175k shares.
- Jason Kim named President and CFO, formalizing his interim CFO role.
- Kristen Quigley named COO; Grace Kim named Chief Strategy Officer and Head of IR.
- Board appoints Harold Selick to Audit Committee, Corsee Sanders to Nominating Committee.

## SEC filing metadata
- accession: 0001193125-23-201733
- form_type: 8-K
- cik: 0001183765
- company_name: Molecular Templates, Inc.
- filed_at: 2023-08-02T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1183765/000119312523201733/0001193125-23-201733-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1183765/000119312523201733/d483079d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-201733
- JSON: https://secwatch.observer/filing/0001193125-23-201733.json
- Plain text: https://secwatch.observer/filing/0001193125-23-201733.txt

## Key facts
- Executive change
  Jason S. Kim was appointed as Chief Financial Officer at Molecular Templates, Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: On August 1, 2023, the Board also appointed Jason S. Kim, the Company’s Interim Chief Financial Officer, as its Chief Financial Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1183765/000119312523201733/0001193125-23-201733-index.htm
- Executive change
  Roger Waltzman resigned as Chief Medical Officer at Molecular Templates, Inc..
  - Action: resigned
  - Role: Chief Medical Officer
  source text: On July 27, 2023, Roger Waltzman, M.D. notified the Board of Directors (the “Board”) of Molecular Templates, Inc. (the “Company”) of his decision to resign from his position as Chief Medical Officer of the Company, effective as of August 4, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1183765/000119312523201733/0001193125-23-201733-index.htm
- Executive change
  Gabriela Gruia was appointed as Interim Chief Medical Officer at Molecular Templates, Inc..
  - Action: appointed
  - Role: Interim Chief Medical Officer
  source text: On August 1, 2023, the Company appointed Gabriela Gruia, M.D. to serve as the Company’s interim Chief Medical Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1183765/000119312523201733/0001193125-23-201733-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.